VNDA – vanda pharmaceuticals inc. (US:NASDAQ)
Stock Stats
News
Vanda Pharmaceuticals (VNDA) is now covered by Truist Financial Corporation. They set a "buy" rating and a $18.00 price target on the stock.
Vanda Announces FDA Grants Landmark Hearing for HETLIOZ® in Jet Lag Disorder, the First Drug Approval Hearing in Over 40 Years [Yahoo! Finance]
Vanda Announces FDA Grants Landmark Hearing for HETLIOZ® in Jet Lag Disorder, the First Drug Approval Hearing in Over 40 Years
Vanda Pharmaceuticals Announces Participation in the 2026 Citizens Life Sciences Conference
Vanda Pharmaceuticals Announces FDA Acceptance of Biologics License Application Filing for Imsidolimab for the Treatment of Generalized Pustular Psoriasis [Yahoo! Finance]
Form 4 Vanda Pharmaceuticals For: Mar 02 Filed by: Williams Timothy
Form 4 Vanda Pharmaceuticals For: Mar 02 Filed by: Moran Kevin Patrick
Form 4 Vanda Pharmaceuticals For: Mar 02 Filed by: Wijkstrom Joakim
Form 4 Vanda Pharmaceuticals For: Mar 02 Filed by: Polymeropoulos Mihael Hristos
Form 4 Vanda Pharmaceuticals For: Mar 02 Filed by: Birznieks Gunther
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.